Em altaUrgenteNovo
PolíticaEsportesCriptoFinançasGeopolíticaResultadosTecnologiaCulturaMundoEconomiaEleições
Will FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
9
350Ṁ195
2027
45%
chance

Resolves YES if the FDA grants full approval for the commercial sale of any mRNA vaccine against non-small-cell lung carcinoma in the United States before January 1, 2028. This does not include emergency use authorization or other forms of limited authorization. Resolves NO otherwise.

Medicine
Health
mRNA vaccines
Biology
Get
Ṁ1,000
to start trading!
Ordenar por:

I think this is second most likely to get approval - very high market demand, high mutational load, already approved for checkpoint inhibitor therapy.

Pessoas também estão operando

Will FDA approve any mRNA vaccine against small-cell lung carcinoma before 2028?
21% chance
Will FDA approve any mRNA vaccine against squamous cell carcinoma before 2028?
35% chance
Will FDA approve any mRNA vaccine against esophageal adenocarcinoma before 2028?
33% chance
Will FDA approve any mRNA vaccine against glioblastoma before 2028?
20% chance
Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028?
41% chance
Will FDA approve any mRNA vaccine against mesothelioma before 2028?
26% chance
Will FDA approve any mRNA vaccine against melanoma before 2028?
48% chance
Will FDA approve any type of personalized cancer mRNA vaccines before 2028?
42% chance
Will FDA approve any mRNA vaccine against colorectal adenocarcinoma before 2028?
31% chance
Will FDA approve any mRNA vaccine against any type of breast cancer before 2028?
31% chance
© Predita Markets, Inc.•Termos de Uso•Privacidade